Krebs Biochemicals & Industries Limited (NSE:KREBSBIO)
India flag India · Delayed Price · Currency is INR
61.81
+2.94 (4.99%)
May 25, 2026, 9:49 AM IST

NSE:KREBSBIO Income Statement

Millions INR. Fiscal year is Apr - Mar.
Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Operating Revenue
237.32433.12504.22521.34597.03
Other Revenue
20.26----
257.58433.12504.22521.34597.03
Revenue Growth (YoY)
-40.53%-14.10%-3.29%-12.68%13.32%
Cost of Revenue
3.91100.3193.99277.16441.18
Gross Profit
253.67332.81410.23244.19155.85
Selling, General & Admin
103.88172.59170.53165.32159.81
Other Operating Expenses
184.03306.24323.98231.74328.01
Operating Expenses
352.15545.72562.17462.65550.79
Operating Income
-98.47-212.91-151.95-218.46-394.94
Interest Expense
-70.86-59.08-46.86-29.71-53.85
Interest & Investment Income
-1.591.561.273.58
Other Non Operating Income (Expenses)
--0.06-0.04-0.02-0.06
EBT Excluding Unusual Items
-169.33-270.46-197.28-246.92-445.27
Gain (Loss) on Sale of Assets
-1.22---
Pretax Income
-169.33-269.24-197.28-246.92-445.27
Income Tax Expense
-0.15---
Net Income
-169.33-269.39-197.28-246.92-445.27
Net Income to Common
-169.33-269.39-197.28-246.92-445.27
Shares Outstanding (Basic)
2222222222
Shares Outstanding (Diluted)
2222222222
Shares Change (YoY)
0.05%---9.89%
EPS (Basic)
-7.85-12.49-9.15-11.45-20.65
EPS (Diluted)
-7.85-12.49-9.15-11.45-20.65
Free Cash Flow
-50.92-114.54-70.5-398.71-442.95
Free Cash Flow Per Share
-2.36-5.31-3.27-18.49-20.54
Gross Margin
98.48%76.84%81.36%46.84%26.11%
Operating Margin
-38.23%-49.16%-30.14%-41.90%-66.15%
Profit Margin
-65.74%-62.20%-39.13%-47.36%-74.58%
Free Cash Flow Margin
-19.77%-26.45%-13.98%-76.48%-74.19%
EBITDA
-34.24-147.86-86.12-154.71-338.36
EBITDA Margin
-13.29%-34.14%-17.08%-29.68%-56.67%
D&A For EBITDA
64.2365.0565.8263.7556.58
EBIT
-98.47-212.91-151.95-218.46-394.94
EBIT Margin
-38.23%-49.16%-30.14%-41.90%-66.15%
Revenue as Reported
257.58440.21508.73527.55608.59
Source: S&P Global Market Intelligence. Standard template. Financial Sources.